HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia.

AbstractOBJECTIVE:
This study explored the efficacy of local methylcobalamin injection in relieving pain and improving the quality of life among subjects with subacute herpetic neuralgia.
DESIGN:
A single-center, randomized controlled trial of local methylcobalamin injection was performed.
SUBJECTS:
Ninety-eight subjects (age, ≥ 50 years) with unilateral, dermatomal pain ≥ 4 related to herpes zoster on the torso lasting for 30 days after onset of rash were enrolled.
METHODS:
Subjects were randomized to receive local methylcobalamin injection (N = 33), oral methylcobalamin (N = 33), or subcutaneous 1.0% lidocaine injection (N = 32) for 4 weeks. Worst pain severity, global impression of change, continuous spontaneous pain, paroxysmal pain, allodynia, paresthesia, interference with activities of daily living, and quality of life were assessed after 28-day treatment period.
RESULTS:
Time per group interaction and group difference on overall pain at each follow-up point were statistically significant (P < 0.001) among groups. In the injected methylcobalamin group, the overall pain (P < 0.001), continuous spontaneous pain (P < 0.05), paroxysmal pain (P < 0.05), and allodynia (P < 0.05) revealed a significant effect at each follow-up point as compared with the other groups. Twenty subjects achieved pain reduction ≥ 50%, 24 perceived worst pain ≤ 3, 24 stopped using analgesics at end point; activities of daily living and quality of life improved significantly as compared with the other groups (P < 0.001). Although both of the other groups showed a significant response after the 14-day treatment (P < 0.001) compared with the baseline, oral methylcobalamin did not provide any significantly pain relief (P > 0.05).
CONCLUSIONS:
Local methylcobalamin injection was not only efficacious in relieving pain, but also appears to be tolerable and a potential choice of treatment for subacute herpetic neuralgia.
AuthorsGang Xu, Zhong-Wei Lv, Yan Feng, Wei-Zhen Tang, Gang Xiao Xu
JournalPain medicine (Malden, Mass.) (Pain Med) Vol. 14 Issue 6 Pg. 884-94 (Jun 2013) ISSN: 1526-4637 [Electronic] England
PMID23566267 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightWiley Periodicals, Inc.
Chemical References
  • mecobalamin
  • Vitamin B 12
Topics
  • Aged
  • China (epidemiology)
  • Comorbidity
  • Drug-Related Side Effects and Adverse Reactions (epidemiology)
  • Female
  • Humans
  • Injections, Subcutaneous
  • Male
  • Neuralgia, Postherpetic (diagnosis, drug therapy, epidemiology)
  • Pain Measurement (drug effects, statistics & numerical data)
  • Prevalence
  • Quality of Life
  • Risk Factors
  • Treatment Outcome
  • Vitamin B 12 (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: